Conventional therapy in IBD, such as 5-ASA (5-aminosalicylic acid), reverses mitochondrial dysfunction by activating Peroxisome proliferator- activated receptor-gamma (PPAR-γ) (84, 99, 100). This evidence concerns the gene PPARG and inflammatory bowel disease.